Cladribine (Mylan Institutional LLC)
Welcome to the PulseAid listing for the Cladribine drug offered from Mylan Institutional LLC. This Purine Antimetabolite [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional LLC |
| NON-PROPRIETARY NAME: | Cladribine |
| SUBSTANCE NAME: | CLADRIBINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Purine Antimetabolite [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-07-10 |
| END MARKETING DATE: | 0000-00-00 |
Cladribine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cladribine from Mylan Institutional LLC |
| LABELER NAME: | Mylan Institutional LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 2011-07-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 67457-450_69aee660-f40b-46e8-97de-0cfc2caf4377 |
| PRODUCT NDC: | 67457-450 |
| APPLICATION NUMBER: | ANDA200510 |
Other CLADRIBINE Pharmaceutical Manufacturers / Labelers:
